The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Clinical Trial Failure

Max Former Hodgkins Stage 3
Max Former Hodgkins Stage 3 CSN Member Posts: 3,831 Member
in Lymphoma (Hodgkin and Non-Hodgkin) #1

I don't think anyone at the Board has mentioned bieng part of this, but it is important to be aware of, especially members with T-cell issues. 

max

http://www.foxnews.com/health/2016/07/08/juno-cancer-study-halted-after-patient-deaths.html

 

.

 

.

Like Care

Comments

  • po18guy
    po18guy CSN Member Posts: 1,572 Member
    edited July 2016 #2
    Strange demographic - 20

    Strange demographic - 20 somethings, and a strange dynamic in the unpredicted and undesireable side effect. I had fludarabine and Cyclophosphamide as conditioning for my transplant (it is SOP at Fred Hutch) and nearly everyone I know maintains that I survived it. This is a huge blow to the trial, but the data, morbid as it is, will certainly help to guide future trials. However, going to a less effective conditioning regimen seems only to guarantee worse overall results. A true catch-22 and sadly, part and parcel of research.  

    Like Care

Discussion Boards